PMID: 20127556Feb 4, 2010Paper

Terrapinn's world influenza congress Europe 2009. Part 2

IDrugs : the Investigational Drugs Journal
Claire Veryard

Abstract

Terrapinn's World Influenza Congress Europe 2009, held in Brussels, included topics covering new developments in the field of influenza vaccination. This conference report highlights selected presentations on the use of novel technologies for developing vaccines for influenza. Investigational vaccines discussed include Multimeric-001 (BiondVax Pharmaceuticals Ltd), NB-1008 (NanoBio Corp) and an influenza vaccine containing the CAF-01 adjuvant (Statens Serum Institut).

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

IDrugs : the Investigational Drugs Journal
Claire Veryard
IDrugs : the Investigational Drugs Journal
Andrea Leone-Bay
IDrugs : the Investigational Drugs Journal
Danny Chan
© 2021 Meta ULC. All rights reserved